Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-GLUCANCER2: Glycosidase Activity in Plasma for Detecting Localized Cancer
NCT07236177Phase 1Recruiting
- Sponsor
- CHU de Poitiers
- Start
- Feb 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 arms), sponsored by CHU de Poitiers. Primary endpoint: Levels of glycosidases in blood samples. Started Feb 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07236177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07236177.